14 results match your criteria: "From the Center for Healthcare Organization and Implementation Research.[Affiliation]"

Changes in Burnout and Moral Distress Among Veterans Health Administration (VA) Physicians Before and During the COVID-19 Pandemic.

J Occup Environ Med

July 2023

From the Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston Healthcare System, Boston, Massachusetts (D.C.M.); Department of Health Policy and Management, Boston University School of Public Health, Boston, Massachusetts (D.C.M.); Center for Study of Healthcare Innovation, Implementation, and Policy (CSHIIP), VA Greater Los Angeles Healthcare System, Los Angeles, California (E.A.A.); RAND Corporation, Santa Monica, California (E.A.A.); Boston University School of Medicine, Boston, Massachusetts (B.M.L.); Center for Healthcare Organization and Implementation Research (CHOIR), VA Bedford Healthcare System, Bedford, Massachusetts (B.K.M-P., S.T.R.); The Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts (S.T.R.).

Background: We investigated the impacts of workload, resources, organizational satisfaction, and psychological safety on changes in physician burnout and moral distress among physicians during the early pandemic.

Methods: We obtained national administrative and survey data on burnout, moral distress, organizational satisfaction, psychological safety, COVID-19 burden, and state-level restrictions for 11,877-14,246 Veterans Health Administration (VA) physicians from 2019 and 2020. We regressed the changes in burnout and moral distress on the changes in reasonable workload, appropriate job resources, organizational satisfaction, and psychological safety, controlling for COVID-19 burden and restrictions, and individual and medical center characteristics.

View Article and Find Full Text PDF

Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.

Neurology

August 2021

From the Center for Healthcare Organization and Implementation Research (CHOIR) (V.L.M.), Edith Nourse Rogers Memorial Veterans Hospital, Bedford; Department of Neurology and Cancer Center (V.L.M., R.T., S.R.P.), Massachusetts General Hospital, Boston; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; Children's Tumor Foundation (I.M., M.H., T.R.), New York, NY; Neurofibromatosis Inc. California (B.O.), Vacaville; Neurofibromatosis Network (B.O.), Wheaton, IL; Littlest Tumor Foundation (T.W.), Appleton, WI; and Pediatric Oncology Branch (P.L.W., A.M.G.), National Cancer Institute, National Institutes of Health, Bethesda, MD.

Objective: As part of an evaluation of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration patient representative program, we surveyed REiNS members to (1) identify facilitators and barriers to involving patient representatives and (2) understand whether and how involving patient representatives affected recommendations for clinical trial outcomes.

Methods: We administered an anonymous online survey to all REiNS members. Facilitators and barriers to patient representative involvement were solicited using a modified free listing technique; responses were inductively grouped into higher-order categories and ranked based on saliency score (Smith ).

View Article and Find Full Text PDF

Objectives: Reducing seclusion and restraint use is a prominent focus of efforts to improve patient safety in inpatient psychiatry. This study examined the poorly understood relationship between seclusion and restraint rates and organizational climate and clinician morale in inpatient psychiatric units.

Methods: Facility-level data on hours of seclusion and physical restraint use in 111 U.

View Article and Find Full Text PDF

Clinical Pharmacist Integration Into Veterans' Primary Care: Team Members Perspectives.

J Am Board Fam Med

September 2021

From the Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, MA (AZ); Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, MA (CG, FK, JIR, NN, DRM, MBM); Pharmacy Benefits Management Services, National Clinical Pharmacy Practice Office, US Department of Veterans Affairs, Washington, DC (MHT, HLO, APM); University of Massachusetts, Lowell, Center for Population Health (DRM); University of Massachusetts, Lowell, Zuckerberg School of Health Sciences, Department of Public Health (MBM).

Background: With the restructuring of primary care into patient-centered medical homes (PCMH), researchers have described role transformations that accompany the formation of core primary care teamlets (eg, primary care provider, registered nurse care manager, licensed practical nurse, medical support assistant). However, few studies offer insight into how primary care teamlets, once established, integrate additional extended team members, and the factors that influence the quality of their integration.

Methods: We examine the process of integrating Clinical Pharmacy Specialists (CPS) into primary care teams in the Veterans Health Administration (VHA).

View Article and Find Full Text PDF

Objectives: Staff values and beliefs about resident safety (safety climate) represent one potential driver of nursing home safety. Staff with more work experience (length of service) may possess richer knowledge of resident safety for strengthening safety climate. We investigated the association of length of service with safety climate in the U.

View Article and Find Full Text PDF

Objectives: Improving nursing home safety is important to the quality of resident care. Increasing evidence points to the relationship between actual safety and a strong safety climate, i.e.

View Article and Find Full Text PDF

An Opportunity to Report Closer-to-Efficacy Findings in a Study of Lamotrigine for Borderline Personality Disorder.

Am J Psychiatry

December 2018

From the Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers VA Medical Center, Bedford, Mass.; and the Departments of Psychiatry and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester.

View Article and Find Full Text PDF

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.

N Engl J Med

August 2017

From the Center for Healthcare Organization and Implementation Research, Bedford Veterans Affairs (VA) Hospital, Bedford (D.R.B., L.E.K.), and Boston University Schools of Medicine and Public Health (D.R.B., L.E.K.) and Tufts Medical Center (D.E.W.), Boston - all in Massachusetts; Wake Forest School of Medicine, Winston-Salem (C.G.F., J.N., N.M.P.), and East Carolina University College of Nursing (L.P.B.) and Brody School of Medicine (J.P.), East Carolina University, Greenville - both in North Carolina; the University of Pittsburgh, Pittsburgh (M.B.C.); Mayo Clinic Florida, Jacksonville (P.F.); the Ohio State Wexner Medical Center, Columbus (T.R.G.); the National Institute of Diabetes and Digestive and Kidney Diseases (P.L.K.) and the National Heart, Lung, and Blood Institute (J.S.), Bethesda, MD; the G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS (K.K.); UCLA Fielding School of Public Health, Los Angeles (D.E.M.); Minneapolis VA Medical Center, Minneapolis (C.O.); University of Alabama at Birmingham, Birmingham (S.O., T.R.); University of Utah School of Medicine (D.L.S., M.A.S.) and VA Geriatric Research, Education and Clinical Center (M.A.S.), Salt Lake City; and the Clement J. Zablocki VA Medical Center, Milwaukee (J.W.).

Background: The previously published results of the Systolic Blood Pressure Intervention Trial showed that among participants with hypertension and an increased cardiovascular risk, but without diabetes, the rates of cardiovascular events were lower among those who were assigned to a target systolic blood pressure of less than 120 mm Hg (intensive treatment) than among those who were assigned to a target of less than 140 mm Hg (standard treatment). Whether such intensive treatment affected patient-reported outcomes was uncertain; those results from the trial are reported here.

Methods: We randomly assigned 9361 participants with hypertension to a systolic blood-pressure target of less than 120 mm Hg or a target of less than 140 mm Hg.

View Article and Find Full Text PDF

Do Acute Myocardial Infarction and Heart Failure Readmissions Flagged as Potentially Preventable by the 3M Potentially Preventable Readmissions Software Have More Process-of-Care Problems?

Circ Cardiovasc Qual Outcomes

September 2016

From the Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VAMC Campus, Bedford, MA (A.M.B.); Department of Health Policy and Management, Boston University School of Public Health, MA (A.M.B.); Department of Medicine (A.M.B., A.H.) and Department of Surgery (H.J.M., A.K.R.), Boston University School of Medicine, MA; CHOIR, Boston VA Campus, MA (Q.C., H.J.M., M.S., A.H., A.K.R.); Boston University Questrom School of Business, MA (M.S.); Brigham and Women's Hospital Heart & Vascular Center, Boston, MA (D.L.B.); and Department of Medicine, Harvard Medical School, Boston, MA (D.L.B.).

Background: The 3M Potentially Preventable Readmissions (3M-PPR) software matches clinically related index admission and readmission diagnoses that may signify in-hospital or postdischarge quality problems. To assess whether the PPR algorithm identifies preventable readmissions, we compared processes of care between PPR software-flagged and nonflagged cases.

Methods And Results: Using 2006 to 2010 national VA administrative data, we identified acute myocardial infarction and heart failure discharges associated with 30-day all-cause readmissions, then flagged cases (PPR-Yes/PPR-No) using the 3M-PPR software.

View Article and Find Full Text PDF

A Call to Reduce the Use of Bridging Anticoagulation.

Circ Cardiovasc Qual Outcomes

January 2016

From the Center for Healthcare Organization and Implementation Research, Bedford VA Medical Center, MA (A.J.R.); Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, MA (A.J.R.); Department of Pharmacy, VA Salt Lake City Healthcare System, UT (A.L.A.); Department of Medicine, San Francisco VA Medical Center, CA (T.M.); and Department of Medicine, University of California San Francisco School of Medicine (T.M.).

Because of the recent publication of several important studies, there has been a major change in how we think about perioperative management of anticoagulation. Because of these changes, existing consensus guidelines are suddenly out of date and can no longer be used as is, particularly the 2012 American College of Chest Physicians Antithrombotic Guidelines, version 9. We estimate that well over 90% of patients receiving warfarin therapy should not receive bridging anticoagulation during periprocedural interruptions of therapy, except under unusual circumstances and with appropriate justification.

View Article and Find Full Text PDF

The Ascendancy of Second-Generation Antipsychotics as Frontline Antimanic Agents.

J Clin Psychopharmacol

December 2015

From *The Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, Boston, MA; †Department of Psychiatry, Harvard Medical School, Boston, MA; ‡The Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial VA Medical Center, Bedford, MA; §Department of Mathematical Sciences, Bentley University, Waltham, MA; ∥Department of Health Services Research, Group Health Research Institute, Seattle, WA; ¶Department of Health Services Research, University of Washington, Seattle, WA; #Research Center for Statistics and Actuarial Science in Medicine, School of Statistics, Xi'an University of Finance and Economics, Xi'an, China; **Department of Surgery, Massachusetts General Hospital, Boston, MA; ††Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA; ‡‡VA Boston Healthcare System, Brockton, MA; and §§Department of Population Medicine, Harvard Pilgrim, Boston, MA.

Introduction: Knowledge of the factors affecting the adoption of new medications can enhance mental health care and guide quality improvement and policy development. Food and Drug Administration indications for treating bipolar disorder with several second-generation antipsychotics (SGAs) in the 2000s represent an opportunity to identify factors that impact the spread of a then-innovative treatment through a new population.

Methods: Analysis of Department of Veterans Affairs administrative data identified the population of 170,811 veterans diagnosed with bipolar disorder from 2003 to 2010.

View Article and Find Full Text PDF

What Is in a Name? How Biomedical Language May Derail Patient Understanding of Hypertension.

Circ Cardiovasc Qual Outcomes

July 2015

From the Center for Healthcare Organization and Implementation Research (CHOIR)-VA HSR&D Center of Innovation, VA Boston Healthcare System and Edith Nourse Rogers Memorial VA Medical Center, Bedford, MA (B.G.B., N.R.K.); Department of Health Policy and Management, Boston University School of Public Health, Boston, MA (B.G.B.); and Section of General Internal Medicine, Boston University School of Medicine, Boston, MA (N.R.K.).

Despite major advances in treating hypertension, >50% of all individuals diagnosed with the condition remain in poor control. A fundamental issue may be that patients may not fully understand the meaning of the term hypertension or its cause, leading to poor adherence to medications and limiting other effective self-management behaviors. We posit that the word hypertension itself may contribute to these misunderstandings, particularly in regards to the role of stress in causing hypertension, which thus suggests stress management as a primary strategy for control.

View Article and Find Full Text PDF

Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.

Circ Cardiovasc Qual Outcomes

September 2014

From the Center for Healthcare Organization and Implementation Research, Bedford VA Medical Center, Bedford, MA (Z.R., A.O., S.Z., G.K.J., A.J.R.); Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA (Z.R., A.J.R.); and Biostatistics Section, Center for Patient Safety and Quality Research, Boston Children's Hospital, Boston, MA (A.O.).

Background: Among patients receiving warfarin, percent time in therapeutic range (TTR) and international normalized ratio (INR) variability predict adverse events individually. Here, we examined what is added to the prediction of adverse events by using both measures together.

Methods And Results: We included 40 404 patients anticoagulated for atrial fibrillation, aged 65+, within the Veterans Health Administration.

View Article and Find Full Text PDF

Stratifying the risks of oral anticoagulation in patients with liver disease.

Circ Cardiovasc Qual Outcomes

May 2014

From the Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial VA Medical Center, Bedford, MA (D.R.B., A.S.A., E.M.H., A.O., J.I.R., S.Z., G.K.J., A.J.R.); Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, MA (L.M.E., D.R.B., A.S.A., E.M.H., A.J.R.); Section of Gastroenterology, Granite Medical Group, Boston University Medical Center, MA (D.S.M.); Department of Health Policy and Management, Boston University School of Public Health, MA (D.R.B., G.K.J.); Division of Biostatistics and Health Services Research, Department of Quantitative Health Sciences, University of Massachusetts School of Medicine, Worcester (A.S.A.); and Biostatistics Section, Boston Children's Hospital, MA (A.O.).

Background: Chronic liver disease presents a relative contraindication to warfarin therapy, but some patients with liver disease nevertheless require long-term anticoagulation. The goal is to identify which patients with liver disease might safely receive warfarin.

Methods And Results: Among 102 134 patients who received warfarin from the Veterans Affairs from 2007 to 2008, International Classification of Diseases-Ninth Revision codes identified 1763 patients with chronic liver disease.

View Article and Find Full Text PDF